Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Altmann

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Ebiomedicine|April 22, 2023
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort studyHarald Hegen, Klaus Berek, Gabriel Bsteh, et al.
Neuroepidemiology|August 30, 2017
Epidemiology of Multiple Sclerosis in AustriaSabine Salhofer-Polanyi, Hakan Cetin, Fritz Leutmezer, et al.
Nature Communications|March 23, 2021
Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophyIsabelle Weinhofer, Paulus Rommer, Bettina Zierfuss, et al.
Nano Letters|September 29, 2018
Intravalley Spin-Flip Relaxation Dynamics in Single-Layer WS<sub>2</sub>Zilong Wang, Alejandro Molina-Sánchez, Patrick Altmann, et al.
Neurology|July 3, 2023
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple SclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 21, 2021
Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic FindingsGerda Ricken, Tobias Zrzavy, Stefan Macher, et al.
Scientific Reports|September 23, 2016
Non-professional marathon running: RAGE axis and ST2 family changes in relation to open-window effect, inflammation and renal functionChristine Bekos, Matthias Zimmermann, Lukas Unger, et al.
European Journal of Neurology|January 31, 2023
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
European Journal of Neurology|December 28, 2020
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC scoreGabriel Bsteh, Harald Hegen, Katharina Riedl, et al.
Annals of Clinical and Translational Neurology|December 17, 2024
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical thresholdGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Ebiomedicine|April 22, 2023
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort studyHarald Hegen, Klaus Berek, Gabriel Bsteh, et al.
Neuroepidemiology|August 30, 2017
Epidemiology of Multiple Sclerosis in AustriaSabine Salhofer-Polanyi, Hakan Cetin, Fritz Leutmezer, et al.
Nature Communications|March 23, 2021
Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophyIsabelle Weinhofer, Paulus Rommer, Bettina Zierfuss, et al.
Nano Letters|September 29, 2018
Intravalley Spin-Flip Relaxation Dynamics in Single-Layer WS<sub>2</sub>Zilong Wang, Alejandro Molina-Sánchez, Patrick Altmann, et al.
Neurology|July 3, 2023
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple SclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 21, 2021
Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic FindingsGerda Ricken, Tobias Zrzavy, Stefan Macher, et al.
Scientific Reports|September 23, 2016
Non-professional marathon running: RAGE axis and ST2 family changes in relation to open-window effect, inflammation and renal functionChristine Bekos, Matthias Zimmermann, Lukas Unger, et al.
European Journal of Neurology|January 31, 2023
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
European Journal of Neurology|December 28, 2020
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC scoreGabriel Bsteh, Harald Hegen, Katharina Riedl, et al.
Annals of Clinical and Translational Neurology|December 17, 2024
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical thresholdGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Pageof 6